Ibrutinib-associated lymphocytosis corresponds to bone marrow involvement in mantle cell lymphoma

被引：14
|
作者：
Furtado, Michelle [1 ,2 ]
Wang, Michael L. [3 ]
Munneke, Brian [4 ]
McGreivy, Jesse [4 ]
Beaupre, Darrin M. [4 ]
Rule, Simon [1 ,2 ]
机构：
[1] Univ Plymouth, Sch Med, Plymouth PL4 8AA, Devon, England
[2] Univ Plymouth, Sch Dent, Plymouth PL4 8AA, Devon, England
[3] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[4] Pharmacyclics Inc, Sunnyvale, CA USA
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2015年 / 170卷 / 01期
关键词：
bone marrow; bruton tyrosine kinase inhibitor; ibrutinib; lymphocytosis; mantle cell lymphoma; BRUTON TYROSINE KINASE; INHIBITOR IBRUTINIB; TARGETING BTK; PCI-32765; LEUKEMIA; DISEASE;
D O I：
10.1111/bjh.13275
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：131 / 134
页数：4
相关论文
共 50 条
  • [31] Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
    Kimura, Yoshizo
    Sato, Kensaku
    Imamura, Yutaka
    Arakawa, Fumiko
    Kiyasu, Junichi
    Takeuchi, Masanori
    Miyoshi, Hiroaki
    Yoshida, Maki
    Niino, Daisuke
    Sugita, Yasuo
    Morito, Toshiaki
    Yoshino, Tadashi
    Nakamura, Shigeo
    Ohshima, Koichi
    CANCER SCIENCE, 2011, 102 (09) : 1734 - 1741
  • [32] Cytogenetic Aberrations Characterize Mantle Cell Lymphoma With Bone Marrow Involvement and Provide The Most Important Prognostic Information
    Yi, Shuhua
    Li, Zengjun
    An, Gang
    Li, Chengwen
    Zou, Dehui
    Qi, Junyuan
    Zhang Peihong
    Qiu, Lugui
    BLOOD, 2013, 122 (21)
  • [33] Cryptococcal meningoencephalitis in patients with mantle cell lymphoma on ibrutinib
    Sun, Kai
    Kasparian, Saro
    Iyer, Swaminathan
    Pingali, Sai Ravi
    ECANCERMEDICALSCIENCE, 2018, 12
  • [34] Overcoming Mantle Cell Lymphoma's Ibrutinib Resistance
    Sinha, Gunjan
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (11):
  • [35] Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation
    D Adkins
    R Brown
    LT Goodnough
    H Khoury
    W Popovic
    J DiPersio
    Bone Marrow Transplantation, 1998, 21 : 97 - 99
  • [36] Treatment of resistant mantle cell lymphoma with allogeneic bone marrow transplantation
    Adkins, D
    Brown, R
    Goodnough, LT
    Khoury, H
    Popovic, W
    DiPersio, J
    BONE MARROW TRANSPLANTATION, 1998, 21 (01) : 97 - 99
  • [37] Can we improve on ibrutinib in mantle cell lymphoma?
    Rule, Simon
    LANCET HAEMATOLOGY, 2018, 5 (03): : E98 - E99
  • [38] Overcoming primary ibrutinib resistance in mantle cell lymphoma
    Zhang, Leo
    Lan Pham
    Zhang, Hui
    Xie, Jingmeng
    Tao, Wenjing
    Bell, Taylor
    Chen, Zhihong
    Nomie, Krystle
    Fang, Bingliang
    Wang, Michael
    CANCER RESEARCH, 2016, 76
  • [39] Perisinusoidal bone marrow involvement by lymphoma
    Stefano Licci
    Marco Rosati
    International Journal of Hematology, 2017, 106 : 1 - 2
  • [40] Perisinusoidal bone marrow involvement by lymphoma
    Licci, Stefano
    Rosati, Marco
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (01) : 1 - 2
12345